Home  |  Contact

Cellosaurus WIL2 NS (CVCL_2761)

[Text version]

Cell line name WIL2 NS
Synonyms WIL2-NS; WIL-2NS; WIL-2-NS; WI-L2 NS; WIL2 Non-Secreting
Accession CVCL_2761
Resource Identification Initiative To cite this cell line use: WIL2 NS (RRID:CVCL_2761)
Comments Group: Hybridoma fusion partner cell line.
Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
Microsatellite instability: Stable (MSS) (Sanger).
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Discontinued: TKG; TKG 0374; probable.
HLA typing Source: IPD-IMGT/HLA; 11561
Class II
HLA-DPDPA1*02:02:02
Genome ancestry Source: PubMed=30894373

Origin% genome
African0
Native American0.61
East Asian, North0
East Asian, South0
South Asian1.47
European, North69.86
European, South28.06
Disease Hereditary spherocytosis (NCIt: C97074)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_6544 (WIL2)
Children:
CVCL_Z045 (HO-323)CVCL_6416 (LTR228)CVCL_2762 (WIL2.NS.6TG)
CVCL_6742 (WTK-1)
Sex of cell Male
Age at sampling 5Y
Category Transformed cell line
STR profile Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; RCB

Markers:
AmelogeninX,Y
CSF1PO11,12
D5S81812,13
D7S8209,12
D13S31711
D16S53911,12
F13A016,7
F13B10
FESFPS11,12
LPL9,10
TH018,9.3 (ATCC; Cosmic-CLP; ECACC; RCB)
8,10 (JCRB)
TPOX8,11
vWA17,20

Run an STR similarity search on this cell line
Publications

Patent=US4806476
Coons T., Avner B.
Efficient cell fusion process.
Patent number US4806476, 21-Feb-1989

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=29892436; DOI=10.1098/rsos.172472
Shioda S., Kasai F., Watanabe K., Kawakami K., Ohtani A., Iemura M., Ozawa M., Arakawa A., Hirayama N., Kawaguchi E., Tano T., Miyata S., Satoh M., Shimizu N., Kohara A.
Screening for 15 pathogenic viruses in human cell lines registered at the JCRB Cell Bank: characterization of in vitro human cells by viral infection.
R. Soc. Open Sci. 5:172472-172472(2018)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

Cross-references
Cell line collections ATCC; CRL-8155
ECACC; 90112121
JCRB; JCRB9063
RCB; RCB2285 - Discontinued
TKG; TKG 0374
Cell line databases/resources CLDB; cl4717
CCLE; WIL2NS_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cell_Model_Passport; SIDM01102
Cosmic-CLP; 1331049
GDSC; 1331049
IPD-IMGT/HLA; 11561
Ontologies BTO; BTO:0001524
CLO; CLO_0009601
CLO; CLO_0009604
Biological sample resources BioSample; SAMN03471196
BioSample; SAMN03472416
Chemistry resources ChEMBL-Cells; CHEMBL3308012
ChEMBL-Targets; CHEMBL612810
Gene expression databases ArrayExpress; E-MTAB-3610
GEO; GSM827461
GEO; GSM1670575
Other Wikidata; Q54994065
Entry history
Entry creation04-Apr-2012
Last entry updated24-May-2019
Version number20